These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 35016558)

  • 1. Practice variations in antibiotic administration for the management of peritonitis in patients on automated peritoneal dialysis in Australia and New Zealand.
    Ling CW; Sud K; Van C; Peterson GM; Patel RP; Zaidi STR; Castelino RL
    Perit Dial Int; 2022 Nov; 42(6):647-651. PubMed ID: 35016558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of culture-directed antibiotics for the treatment of peritonitis in automated peritoneal dialysis: A systematic narrative review.
    Ling CW; Sud K; Van C; Zaidi STR; Patel RP; Peterson GM; Castelino RL
    Perit Dial Int; 2021 May; 41(3):261-272. PubMed ID: 33559525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of peritonitis in APD: pharmacokinetic principles.
    Manley HJ; Bailie GR
    Semin Dial; 2002; 15(6):418-21. PubMed ID: 12437537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peritonitis and antibiotic therapy in patients on cycler peritoneal dialysis--an update.
    Diaz-Buxo JA; Crawford TL
    Adv Perit Dial; 2000; 16():229-32. PubMed ID: 11045300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review of Antibiotic Dosing with Peritonitis in APD.
    Mancini A; Piraino B
    Perit Dial Int; 2019; 39(4):299-305. PubMed ID: 31296775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association between peritoneal dialysis modality and peritonitis.
    Lan PG; Johnson DW; McDonald SP; Boudville N; Borlace M; Badve SV; Sud K; Clayton PA
    Clin J Am Soc Nephrol; 2014 Jun; 9(6):1091-7. PubMed ID: 24626434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vancomycin disposition following intraperitoneal administration in children receiving peritoneal dialysis.
    Blowey DL; Warady BA; Abdel-Rahman S; Frye RF; Manley HJ
    Perit Dial Int; 2007; 27(1):79-85. PubMed ID: 17179516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous ambulatory peritoneal dialysis and automated peritoneal dialysis: are there differences in outcome?
    Dell'Aquila R; Berlingò G; Pellanda MV; Contestabile A
    Contrib Nephrol; 2009; 163():292-299. PubMed ID: 19494628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vancomycin in peritoneal dialysis: Clinical pharmacology considerations in therapy.
    Lam E; Lien YTK; Kraft WK; Piraino B; Vozmediano V; Schmidt S; Zhang J
    Perit Dial Int; 2020 Jul; 40(4):384-393. PubMed ID: 32065053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of bolus intraperitoneal aminoglycosides for treating peritonitis in end-stage renal disease patients receiving continuous ambulatory peritoneal dialysis and continuous cycling peritoneal dialysis.
    Mars RL; Moles K; Pope K; Hargrove P
    Adv Perit Dial; 2000; 16():280-4. PubMed ID: 11045311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved patient/technique survival and peritonitis rates in patients treated with automated peritoneal dialysis when compared to continuous ambulatory peritoneal dialysis in a Mexican PD center.
    Sanchez AR; Madonia C; Rascon-Pacheco RA
    Kidney Int Suppl; 2008 Apr; (108):S76-80. PubMed ID: 18379553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of Intraperitoneal Cefalothin and Cefazolin in Patients Being Treated for Peritoneal Dialysis-Associated Peritonitis.
    Roberts DM; Ranganathan D; Wallis SC; Varghese JM; Kark A; Lipman J; Roberts JA
    Perit Dial Int; 2016; 36(4):415-20. PubMed ID: 26764340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of peritonitis in automated peritoneal dialysis patients.
    Diaz-Buxo JA
    Adv Perit Dial; 1998; 14():131-6. PubMed ID: 10649710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment for peritoneal dialysis-associated peritonitis.
    Ballinger AE; Palmer SC; Wiggins KJ; Craig JC; Johnson DW; Cross NB; Strippoli GF
    Cochrane Database Syst Rev; 2014 Apr; 2014(4):CD005284. PubMed ID: 24771351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peritonitis - does peritoneal dialysis modality make a difference?
    Piraino B; Sheth H
    Blood Purif; 2010; 29(2):145-9. PubMed ID: 20093820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of peritonitis in children on peritoneal dialysis: a 25-year experience at Severance Hospital.
    Lee KO; Park SJ; Kim JH; Lee JS; Kim PK; Shin JI
    Yonsei Med J; 2013 Jul; 54(4):983-9. PubMed ID: 23709435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment and outcome of peritonitis in automated peritoneal dialysis, using a once-daily cefazolin-based regimen.
    Fielding RE; Clemenger M; Goldberg L; Brown EA
    Perit Dial Int; 2002; 22(3):345-9. PubMed ID: 12227392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Similar peritonitis outcome in CAPD and APD patients with dialysis modality continuation during peritonitis.
    Rüger W; van Ittersum FJ; Comazzetto LF; Hoeks SE; ter Wee PM
    Perit Dial Int; 2011; 31(1):39-47. PubMed ID: 20558813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative analysis on the incidence of peritonitis and exit-site infection in CAPD and automated peritoneal dialysis.
    Rodríguez-Carmona A; Pérez Fontán M; García Falcón T; Fernández Rivera C; Valdés F
    Perit Dial Int; 1999; 19(3):253-8. PubMed ID: 10433162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of direct medical costs between automated and continuous ambulatory peritoneal dialysis.
    Cortés-Sanabria L; Rodríguez-Arreola BE; Ortiz-Juárez VR; Soto-Molina H; Pazarín-Villaseñor L; Martínez-Ramírez HR; Cueto-Manzano AM
    Perit Dial Int; 2013; 33(6):679-86. PubMed ID: 23547280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.